Welcure Drugs & Pharmaceuticals Ltd

NSE: WELCURE · BSE: 524661 · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹0.19
Market cap: ₹23.48 Cr
Revenue (annual): ₹365.5 Cr
Net profit (annual): ₹-5.49 Cr
P/E (TTM): -1.4×Sector 43.8×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Debt & Borrowing 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Apr 2026 11:53 IST BSE

Debt & Borrowing

Welcure Drugs & Pharmaceuticals Debt & Borrowing

Welcure Drugs & Pharmaceuticals Ltd confirmed it does not meet SEBI's 'Large Corporate' criteria for the financial year ended March 31, 2026. Consequently, the company is exempt from mandatory incremental borrowing through debt securities. Its outstanding borrowings as of the reporting date were nil.

Open announcement → Read the filing ↗